Lexeo Therapeutics Inc (LXEO)

R&D Expense Growth

21.17%

Quarterly · Period ending:

LXEO logo

LXEO R&D Expense Growth

Latest reported21.17%
LXEO Quarterly R&D Growth (QoQ) (0.00% → 21.17%)
High-resolution chart · PNG

LXEO r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lexeo Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
21.1679%
-3.1277%
3.2813%
6.6164%
-14.2682%
-6.5066%
-21.5899%
41.4432%
5.1963%
91.7418%
-52.3948%
53.4888%
-31.6462%
44.3576%
-25.8755%
25.2303%
20.9004%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.